Developer docs
API playgroundTry for free, no card

Search company profiles

Epiconcept

Full company profile

uuid000b9rf

Namestring
Epiconcept
Legal namestring
Epiconcept SAS
Websiteurl
epiconcept.fr
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Epiconcept is a French privately-held SaaS software publisher founded in 1996 and headquartered in Paris, specializing in public health information systems, epidemiological surveillance, and biostatistics services. The company serves public health institutions, government health agencies, hospitals, research organizations, and international NGOs across approximately 50 countries, with named customers including WHO, ECDC, Santé Publique France, AP-HP, INSERM, and Médecins Sans Frontières. Its product portfolio is anchored on the proprietary Voozanoo/Epicraft technical framework and organized around the Suite Santé Prévention (SSP) integrated suite — covering vaccination (Vaxi), STI/HIV screening (Cupidon), tuberculosis (Damoc), cancer screening (e-SIS 3D), and neonatal screening (Neonat) — alongside a parallel Epiconcept ONG line (Homère, Saga, Saga Stock) serving humanitarian organizations.

The company operates a sales-led, enterprise field motion targeting institutional buyers, distributing through public procurement frameworks UGAP (2023–2027), Resah (2020–2028), and UniHA LOGMED (2024–2028), as well as direct sales to supranational bodies. Revenue is generated through SaaS subscriptions, custom development projects using Voozanoo/Epicraft, and applied epidemiology/biostatistics professional services. All hosting runs on ISO 27001/HDS-certified infrastructure (certified since 2019; HDS accreditation since 2012), a regulatory prerequisite for handling French personal health data. The company reached 100+ employees in 2023, opened capital to Groupe Softway Medical in 2024, and became a Société à Mission in May 2025 with public health purpose statements embedded in its bylaws.

Short descriptiontext

Epiconcept is a Paris-based SaaS publisher founded in 1996 that builds public health information systems, screening/vaccination management suites, and epidemiological surveillance tools for government health agencies, hospitals, and international NGOs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
public health software, disease surveillance systems, epidemiology services, health data warehouse, screening management software
Industry4 codes
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACABAD
API Management & Developer Portals for Health Data
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACAOAA
Electronic Data Capture (EDC) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYBPADAEAH
Health Systems Strengthening & Global Health Technical Assistance
Business & Public Services/International Organizations & Development/International Development & Technical Assistance
NAICS code3 codes
  • Software Publishers513210
  • Computer Systems Design and Related Services54151
  • Scientific Research and Development Services5417
SIC code3 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming Services7371
  • Services-Computer Integrated Systems Design7373
Product category
Public Health Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS Software Subscriptions
TypeSubscription Recurring
Description

Recurring subscription revenue from proprietary SaaS health software solutions including Suite Santé Prévention, Vaxi, Cupidon, Damoc, Neonat, E-SIS, Homère, Saga, and Saga Stock. Delivered via web with cloud hosting and maintenance included.

epiconcept.fr
2Custom Development Projects
TypeProfessional Services
Description

Custom health information system development using Voozanoo/Epicraft framework. Includes co-construction methodology, agile project management, and ongoing support. Services include system design, implementation, and maintenance for specific institutional requirements.

epiconcept.fr
3Epidemiology Services
TypeProfessional Services
Description

Applied research coordination, epidemiological surveillance support, biostatistics services, and training. Services include protocol development, data analysis, and capacity building for public health organizations.

epiconcept.fr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Pricing details3 tiers
1SaaS licensing via UGAP multi-éditeurs market
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Licenses available in acquisition and rental modes, on remote servers (SaaS mode) or on-premise installation. April 2023 - April 2027 framework agreement.

epiconcept.fr
2Resah multi-éditeurs market
ModelSubscriptionBilling cadenceMulti-year contract
Notes

October 2020 - October 2028 framework agreement for health sector public and private non-profit buyers.

epiconcept.fr
3UniHA LOGMED market
ModelSubscriptionBilling cadenceMulti-year contract
Notes

September 2024 - June 2028 for medical software through cooperative purchasing.

epiconcept.fr
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 13 records shown
1Suite Santé Prévention
Description

Comprehensive prevention and screening management suite for health programs including vaccination, IST/Hepatitis/HIV screening, cancer screening, neonatal screening, and tuberculosis.

epiconcept.fr
+12 more records
Core offering1 text field

Epiconcept develops and operates SaaS e-health software for public health actors, including the Suite Santé Prévention (SSP) and its modules for vaccination and screening management (Cupidon, Vaxi, Damoc, e-SIS 3D, Neonat), NGO solutions (Homère, Saga, Saga Stock), and a Health Data Warehouse (EDS). All solutions are built on the proprietary Voozanoo/Epicraft platform and delivered via 100% web-based SaaS with ISO 27001/HDS-certified hosting, complemented by custom development, epidemiology, and biostatistics services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Nearly 100% of neonates born in France screened through NéoNat solution
+5 more records
Product overview1 text field

Epiconcept offers a comprehensive e-health SaaS product portfolio centered on prevention, screening, and public health management. The Suite Santé Prévention (SSP) serves as the core integrated platform managing cross-cutting screening and vaccination programs, with specialized modules including Cupidon (IST/VIH screening), Vaxi (vaccination), Damoc (tuberculosis), e-SIS 3D (cancer screening), and Neonat (neonatal screening). The company also provides the Voozanoo/Epicraft technical framework for custom health information systems, Health Data Warehouse (EDS) services, and a dedicated NGO solutions brand (Epiconcept ONG) with Homère, Saga, and Saga Stock for humanitarian organizations. Epiconcept operates 100% web-based software solutions serving 50,000+ health professionals across 12+ million beneficiaries.

Product and service1 record
1Suite Santé Prévention (SSP)
Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

In 2024, Epiconcept opened capital to Groupe Softway Medical, an actor complementary in the health sector sharing the same vision. This strategic partnership enables complementarity in e-health, data science, and epidemiology at the service of population health. The four original associates (Loïc Flachet, Guillaume Jeannerod, Valérie Nancey, Etienne Sévin) continue to lead the company under this new shareholder structure.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Epiconcept is a member of the Healthcare Data Institute, an organization focused on health data innovation and best practices.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Epiconcept is a member of Medicen, the French competitiveness cluster for digital health, supporting innovation in health technologies.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

UGAP multi-éditeurs market agreement (April 2023 - April 2027) enables public buyers to acquire Epiconcept software solutions through the UGAP catalog, including licenses, maintenance, and support services. The agreement covers standard software and specific professional services.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Resah multi-éditeurs market (2020-2028) and Apollo market (2024-2028) provide framework agreements through which health sector buyers can procure Epiconcept solutions. Resah serves over 1700 establishments in French healthcare sector.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

UniHA LOGMED market (September 2024 - June 2028) for medical software enables public hospitals to acquire Epiconcept solutions through the cooperative purchasing organization.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Epiconcept provides ongoing technical support to ECDC for surveillance projects including VEBIS vaccine effectiveness studies, SARI surveillance, EPHESUS evaluation, Legionnaires' disease surveillance, ArboRisk, and R training programs. The partnership involves development of R packages, protocols, and multi-country analyses.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Epiconcept supports WHO in European Region, African Region, and Eastern Mediterranean Region for COVID-19 and influenza vaccine effectiveness networks. Activities include developing generic protocols, technical support to countries, pooling data, and capacity building through workshops and training.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Epiconcept participates in Horizon 2020 research projects including PANDEM (pandemic preparedness), SpIDnet, and I-MOVE+. Coordinates European surveillance networks and vaccine effectiveness studies funded by European Commission.

10France Cohortes
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Epiconcept supports population cohort management for French longitudinal studies including ELFE, SEPAGES, AGRICAN, and COSET registries.

epiconcept.fr
Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Veeva is the leading life sciences cloud platform covering EDC (Veeva EDC), CTMS, ePRO and clinical data. As a broad incumbent in clinical and life sciences informatics, it represents the upper-end benchmark for what a scaled version of Epiconcept's e-clinical stack could look like.

TypeDirect peer
Description

Enovacom, the healthcare data interoperability arm of Orange Business, provides HIE, health data hosting and integration solutions for French hospitals and public health agencies. It competes with Epiconcept in the EDS/health data warehouse and HDS-certified interoperability space.

TypeDirect peer
Description

Castor is a cloud-based EDC platform used for clinical and observational studies, registries and real-world data capture — closely comparable to Epiconcept's Epistudy, Wepi and Voozanoo-based study management offerings for epidemiological research.

TypeDirect peer
Description

OpenHealth is a French health-data observability and epidemiology firm providing real-world evidence, public health indicators and disease surveillance analytics — overlapping with Epiconcept's data science, surveillance and EDS offerings for French public health actors.

5Maincare (Dedalus)
TypeDirect peer
Description

Maincare, a Dedalus Group subsidiary, is one of the largest French e-health IT vendors serving hospitals, regional health agencies and public health programs with EHR, patient records and screening platforms. It is the most direct French competitor to Epiconcept's public health information systems and SSP suite.

TypeOthers
Description

Groupe Softway Medical is Epiconcept's parent company following the 2024 capital opening; it is a French e-health group focused on hospital information systems. Listed as an ecosystem/parent peer given it provides shared distribution (SantExpo, group sales channel) and a comparable French e-health software franchise.

7Doctolib (REEPORT)
TypeEmerging player
Description

Doctolib acquired REEPORT, a French cancer screening management solution that competes with Epiconcept's e-SIS 3D. As Doctolib pushes deeper into coordination of organized screening programs, REEPORT is an emerging adjacent/competing offering to Epiconcept's SSP module.

TypeBroad incumbent
Description

Dedalus is the parent of Maincare and one of the largest European healthcare IT groups, with deep presence in hospital, diagnostic and public health information systems. It is the most relevant group-level incumbent competing head-to-head with Epiconcept in French and EU public health tenders.

TypeBroad incumbent
Description

CompuGroup Medical is a major European healthcare IT vendor providing EHR, hospital information systems and physician practice software across multiple European countries — overlapping with Epiconcept's public health/regional health agency footprint in France and beyond.

TypeBroad incumbent
Description

Medidata, owned by Dassault Systèmes, is the dominant EDC/CTMS/RTSM platform for clinical trials globally. While broader and more pharma-focused than Epiconcept, it overlaps with Epiconcept's Voozanoo-based EDC and clinical study tooling.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature16 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Epiconcept

Public Health Softwareepiconcept.fr

Epiconcept is a Paris-based SaaS publisher founded in 1996 that builds public health information systems, screening/vaccination management suites, and epidemiological surveillance tools for government health agencies, hospitals, and international NGOs.

What Epiconcept does

Epiconcept is a French privately-held SaaS software publisher founded in 1996 and headquartered in Paris, specializing in public health information systems, epidemiological surveillance, and biostatistics services. The company serves public health institutions, government health agencies, hospitals, research organizations, and international NGOs across approximately 50 countries, with named customers including WHO, ECDC, Santé Publique France, AP-HP, INSERM, and Médecins Sans Frontières. Its product portfolio is anchored on the proprietary Voozanoo/Epicraft technical framework and organized around the Suite Santé Prévention (SSP) integrated suite — covering vaccination (Vaxi), STI/HIV screening (Cupidon), tuberculosis (Damoc), cancer screening (e-SIS 3D), and neonatal screening (Neonat) — alongside a parallel Epiconcept ONG line (Homère, Saga, Saga Stock) serving humanitarian organizations.

The company operates a sales-led, enterprise field motion targeting institutional buyers, distributing through public procurement frameworks UGAP (2023–2027), Resah (2020–2028), and UniHA LOGMED (2024–2028), as well as direct sales to supranational bodies. Revenue is generated through SaaS subscriptions, custom development projects using Voozanoo/Epicraft, and applied epidemiology/biostatistics professional services. All hosting runs on ISO 27001/HDS-certified infrastructure (certified since 2019; HDS accreditation since 2012), a regulatory prerequisite for handling French personal health data. The company reached 100+ employees in 2023, opened capital to Groupe Softway Medical in 2024, and became a Société à Mission in May 2025 with public health purpose statements embedded in its bylaws.

Epiconcept firmographics

Firmographics
Name
Epiconcept
Legal name
Epiconcept SAS
Website
https://epiconcept.fr
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
101–250 employees
Short description
Epiconcept is a Paris-based SaaS publisher founded in 1996 that builds public health information systems, screening/vaccination management suites, and epidemiological surveillance tools for government health agencies, hospitals, and international NGOs.
Ownership category
akta.pro rank

Epiconcept industry classification

Industry
Product category
Public Health Software
NAICS
Software Publishers (513210), Computer Systems Design and Related Services (54151), Scientific Research and Development Services (5417)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming Services (7371), Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACABAD
API Management & Developer Portals for Health Data
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACAOAA
Electronic Data Capture (EDC) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYBPADAEAH
Health Systems Strengthening & Global Health Technical Assistance
Business & Public Services/International Organizations & Development/International Development & Technical Assistance

Keywords

  • Public health software
  • Disease surveillance systems
  • Epidemiology services
  • Health data warehouse
  • Screening management software

Where Epiconcept is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Epiconcept business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. SaaS Software Subscriptions: Recurring subscription revenue from proprietary SaaS health software solutions including Suite Santé Prévention, Vaxi, Cupidon, Damoc, Neonat, E-SIS, Homère, Saga, and Saga Stock. Delivered via web with cloud hosting and maintenance included.
  2. Custom Development Projects: Custom health information system development using Voozanoo/Epicraft framework. Includes co-construction methodology, agile project management, and ongoing support. Services include system design, implementation, and maintenance for specific institutional requirements.
  3. Epidemiology Services: Applied research coordination, epidemiological surveillance support, biostatistics services, and training. Services include protocol development, data analysis, and capacity building for public health organizations.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractSaaS licensing via UGAP multi-éditeurs market
SubscriptionMulti-year contractResah multi-éditeurs market
SubscriptionMulti-year contractUniHA LOGMED market

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Epiconcept product offering

Product offering

Core offering

Epiconcept develops and operates SaaS e-health software for public health actors, including the Suite Santé Prévention (SSP) and its modules for vaccination and screening management (Cupidon, Vaxi, Damoc, e-SIS 3D, Neonat), NGO solutions (Homère, Saga, Saga Stock), and a Health Data Warehouse (EDS). All solutions are built on the proprietary Voozanoo/Epicraft platform and delivered via 100% web-based SaaS with ISO 27001/HDS-certified hosting, complemented by custom development, epidemiology, and biostatistics services.

Product overview

Epiconcept offers a comprehensive e-health SaaS product portfolio centered on prevention, screening, and public health management. The Suite Santé Prévention (SSP) serves as the core integrated platform managing cross-cutting screening and vaccination programs, with specialized modules including Cupidon (IST/VIH screening), Vaxi (vaccination), Damoc (tuberculosis), e-SIS 3D (cancer screening), and Neonat (neonatal screening). The company also provides the Voozanoo/Epicraft technical framework for custom health information systems, Health Data Warehouse (EDS) services, and a dedicated NGO solutions brand (Epiconcept ONG) with Homère, Saga, and Saga Stock for humanitarian organizations. Epiconcept operates 100% web-based software solutions serving 50,000+ health professionals across 12+ million beneficiaries.

Differentiator

Problem solved

Functional benefit

Brands

  • Suite Santé Prévention: Comprehensive prevention and screening management suite for health programs including vaccination, IST/Hepatitis/HIV screening, cancer screening, neonatal screening, and tuberculosis.
  • Vaxi
  • Cupidon
  • Damoc
  • e-SIS 3D
  • Neonat
  • Wepi
  • Epifiles
  • Voozanoo
  • Epistudy
  • Homère
  • Saga
  • Saga Stock

Products and services

  • Suite Santé Prévention (SSP)

Quantifiable outcome

  • Nearly 100% of neonates born in France screened through NéoNat solution
  • +5 more outcomes

Companies that use Epiconcept

Customer profile

Named customers13 records

Segments5 records

Ideal customer profiles5 records

Epiconcept technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature16 records

Epiconcept partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • Groupe Softway MedicalcoreStrategic or Co-development Partner · 1 January 2024In 2024, Epiconcept opened capital to Groupe Softway Medical, an actor complementary in the health sector sharing the same vision. This strategic partnership enables complementarity in e-health, data science, and epidemiology at the service of population health. The four original associates (Loïc Flachet, Guillaume Jeannerod, Valérie Nancey, Etienne Sévin) continue to lead the company under this new shareholder structure.
  • Healthcare Data InstituteminorStrategic or Co-development PartnerEpiconcept is a member of the Healthcare Data Institute, an organization focused on health data innovation and best practices.
  • MedicenminorStrategic or Co-development PartnerEpiconcept is a member of Medicen, the French competitiveness cluster for digital health, supporting innovation in health technologies.
  • UGAP (Union des Groupements d'Achats Publics)coreChannel Partner/ Reseller/ DistributorUGAP multi-éditeurs market agreement (April 2023 - April 2027) enables public buyers to acquire Epiconcept software solutions through the UGAP catalog, including licenses, maintenance, and support services. The agreement covers standard software and specific professional services.
  • Resah (Réseau des Acheteurs Hospitaliers)coreChannel Partner/ Reseller/ DistributorResah multi-éditeurs market (2020-2028) and Apollo market (2024-2028) provide framework agreements through which health sector buyers can procure Epiconcept solutions. Resah serves over 1700 establishments in French healthcare sector.
  • UniHA (L'Achat Coopératif des Hôpitaux Publics)coreChannel Partner/ Reseller/ DistributorUniHA LOGMED market (September 2024 - June 2028) for medical software enables public hospitals to acquire Epiconcept solutions through the cooperative purchasing organization.
  • European Centre for Disease Prevention and Control (ECDC)coreStrategic or Co-development PartnerEpiconcept provides ongoing technical support to ECDC for surveillance projects including VEBIS vaccine effectiveness studies, SARI surveillance, EPHESUS evaluation, Legionnaires' disease surveillance, ArboRisk, and R training programs. The partnership involves development of R packages, protocols, and multi-country analyses.
  • World Health Organization (WHO)coreStrategic or Co-development PartnerEpiconcept supports WHO in European Region, African Region, and Eastern Mediterranean Region for COVID-19 and influenza vaccine effectiveness networks. Activities include developing generic protocols, technical support to countries, pooling data, and capacity building through workshops and training.
  • European CommissioncoreStrategic or Co-development PartnerEpiconcept participates in Horizon 2020 research projects including PANDEM (pandemic preparedness), SpIDnet, and I-MOVE+. Coordinates European surveillance networks and vaccine effectiveness studies funded by European Commission.
  • France CohortesminorStrategic or Co-development PartnerEpiconcept supports population cohort management for French longitudinal studies including ELFE, SEPAGES, AGRICAN, and COSET registries.

Scale indicators11 records

Recent moves12 records

Expansion highlights6 records

Epiconcept competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Veeva is the leading life sciences cloud platform covering EDC (Veeva EDC), CTMS, ePRO and clinical data. As a broad incumbent in clinical and life sciences informatics, it represents the upper-end benchmark for what a scaled version of Epiconcept's e-clinical stack could look like.
  • Dedalus Group: Dedalus is the parent of Maincare and one of the largest European healthcare IT groups, with deep presence in hospital, diagnostic and public health information systems. It is the most relevant group-level incumbent competing head-to-head with Epiconcept in French and EU public health tenders.
  • CompuGroup Medical: CompuGroup Medical is a major European healthcare IT vendor providing EHR, hospital information systems and physician practice software across multiple European countries — overlapping with Epiconcept's public health/regional health agency footprint in France and beyond.
  • Medidata Solutions (Dassault Systèmes): Medidata, owned by Dassault Systèmes, is the dominant EDC/CTMS/RTSM platform for clinical trials globally. While broader and more pharma-focused than Epiconcept, it overlaps with Epiconcept's Voozanoo-based EDC and clinical study tooling.

Direct peers

  • Enovacom (Orange Business): Enovacom, the healthcare data interoperability arm of Orange Business, provides HIE, health data hosting and integration solutions for French hospitals and public health agencies. It competes with Epiconcept in the EDS/health data warehouse and HDS-certified interoperability space.
  • Castor (EDC): Castor is a cloud-based EDC platform used for clinical and observational studies, registries and real-world data capture — closely comparable to Epiconcept's Epistudy, Wepi and Voozanoo-based study management offerings for epidemiological research.
  • OpenHealth: OpenHealth is a French health-data observability and epidemiology firm providing real-world evidence, public health indicators and disease surveillance analytics — overlapping with Epiconcept's data science, surveillance and EDS offerings for French public health actors.
  • Maincare (Dedalus): Maincare, a Dedalus Group subsidiary, is one of the largest French e-health IT vendors serving hospitals, regional health agencies and public health programs with EHR, patient records and screening platforms. It is the most direct French competitor to Epiconcept's public health information systems and SSP suite.

Others

  • Groupe Softway Medical: Groupe Softway Medical is Epiconcept's parent company following the 2024 capital opening; it is a French e-health group focused on hospital information systems. Listed as an ecosystem/parent peer given it provides shared distribution (SantExpo, group sales channel) and a comparable French e-health software franchise.

Emerging players

  • Doctolib (REEPORT): Doctolib acquired REEPORT, a French cancer screening management solution that competes with Epiconcept's e-SIS 3D. As Doctolib pushes deeper into coordination of organized screening programs, REEPORT is an emerging adjacent/competing offering to Epiconcept's SSP module.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Epiconcept social profiles

Digital presence

Epiconcept compliance and trust

Trust signal

Compliance6 records

Epiconcept financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Epiconcept leadership team

Management profile

Number of profiles

Profiles17 records

Epiconcept subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Epiconcept funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Epiconcept M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Epiconcept

What does Epiconcept do?

Epiconcept develops and operates SaaS e-health software for public health actors, including the Suite Santé Prévention (SSP) and its modules for vaccination and screening management (Cupidon, Vaxi, Damoc, e-SIS 3D, Neonat), NGO solutions (Homère, Saga, Saga Stock), and a Health Data Warehouse (EDS). All solutions are built on the proprietary Voozanoo/Epicraft platform and delivered via 100% web-based SaaS with ISO 27001/HDS-certified hosting, complemented by custom development, epidemiology, and biostatistics services.

Is Epiconcept a public or private company?

Epiconcept is a private company. It is classified as corporate owned and is currently operating.

When was Epiconcept founded?

Epiconcept was founded in 1996. It employs 101 to 250 people.

Where is Epiconcept based?

Epiconcept is headquartered in Paris, France, in the Europe region.

How does Epiconcept make money?

Three revenue lines are on record. SaaS Software Subscriptions are the primary driver. The others are custom Development Projects and epidemiology Services.

Who are Epiconcept's main competitors?

Broad incumbents on record are Veeva Systems, Dedalus Group, CompuGroup Medical and Medidata Solutions (Dassault Systèmes). Direct peers are Enovacom (Orange Business), Castor (EDC), OpenHealth and Maincare (Dedalus). Groupe Softway Medical is listed as an others. Doctolib (REEPORT) is listed as an emerging player.

Does Epiconcept have an API?

No public API is recorded for Epiconcept.

What industry is Epiconcept in?

Epiconcept's product category is Public Health Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACABAD, API Management & Developer Portals for Health Data. Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals